SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.
Clinical trial NCT05461170 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05461170
- Sponsor
- Vir Biotechnology, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-17
- Primary completion
- 2031-11-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.